News

A new study in the New England Journal of Medicine led by Dr. Louis Aronne, director of the Comprehensive Weight Control Center and the Sanford I. Weill Professor of Metabolic Research in the division of Endocrinology, Diabetes and Metabolism, shows tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a 72-week clinical trial that compared the safety and efficacy of the injectable drugs. When both drugs are...

Thousands of bacterial and other microbial species live in the human gut, supporting healthy digestion, immunity, metabolism and other functions. Precisely how these microbes are protected from immune attack has been unclear, but now a study led by Weill Cornell Medicine investigators has found that this immune “tolerance” to gut microbes depends on an ancient bacterial-sensing protein called STING—normally considered a trigger for inflammation. The surprising result could lead to new...

Dr. Arnab Ghosh, assistant professor of medicine in the Division of General Internal Medicine, has been selected as an Emerging Leader in Health and Medicine Scholar. The program, part of the National Academy of Medicine, provides opportunities for future health care leaders to collaborate with its members and the other selected Scholars, address persistent challenges and drive transformative change.

“Dr. Ghosh's multi-faceted expertise as a clinician, social scientist and policy-...

Quality Improvement Academy Class of 2025

The Annual Quality Improvement and Patient Safety (QIPS) Poster Symposium took place on May 21, 2025, at the Griffis Faculty Club. The event has brought together institutional leaders, clinicians, researchers and staff across all disciplines to celebrate the impactful and collaborative advancements in patient care for over a decade

This year’s symposium was supported through the co-sponsorship of the Quality...